SI1501828T1 - Piperazin-benzotiazoli kot sredstva za zdravljenje cerebralnih ishemicnih motenj/okvar ali motenj/okvar centralnega živcnega sistema - Google Patents

Piperazin-benzotiazoli kot sredstva za zdravljenje cerebralnih ishemicnih motenj/okvar ali motenj/okvar centralnega živcnega sistema

Info

Publication number
SI1501828T1
SI1501828T1 SI200331114T SI200331114T SI1501828T1 SI 1501828 T1 SI1501828 T1 SI 1501828T1 SI 200331114 T SI200331114 T SI 200331114T SI 200331114 T SI200331114 T SI 200331114T SI 1501828 T1 SI1501828 T1 SI 1501828T1
Authority
SI
Slovenia
Prior art keywords
disorders
piperazine
treatment
benzothiazoles
agents
Prior art date
Application number
SI200331114T
Other languages
English (en)
Slovenian (sl)
Inventor
P Domaine De La Prasl Gaillard
Jean-Pierre Gotteland
Pierre-Alain Vitte
Original Assignee
Labortories Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labortories Serono Sa filed Critical Labortories Serono Sa
Publication of SI1501828T1 publication Critical patent/SI1501828T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SI200331114T 2002-04-25 2003-04-25 Piperazin-benzotiazoli kot sredstva za zdravljenje cerebralnih ishemicnih motenj/okvar ali motenj/okvar centralnega živcnega sistema SI1501828T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02100417 2002-04-25
PCT/EP2003/004323 WO2003091249A1 (en) 2002-04-25 2003-04-25 Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or cns disorders
EP03727365A EP1501828B1 (en) 2002-04-25 2003-04-25 Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or cns disorders

Publications (1)

Publication Number Publication Date
SI1501828T1 true SI1501828T1 (sl) 2008-04-30

Family

ID=29265991

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200331114T SI1501828T1 (sl) 2002-04-25 2003-04-25 Piperazin-benzotiazoli kot sredstva za zdravljenje cerebralnih ishemicnih motenj/okvar ali motenj/okvar centralnega živcnega sistema

Country Status (22)

Country Link
US (1) US7314878B2 (enExample)
EP (1) EP1501828B1 (enExample)
JP (1) JP4523289B2 (enExample)
KR (1) KR100948469B1 (enExample)
CN (1) CN1310911C (enExample)
AT (1) ATE383356T1 (enExample)
AU (1) AU2003233067B2 (enExample)
BR (1) BRPI0309594A8 (enExample)
CA (1) CA2481763C (enExample)
CY (1) CY1107204T1 (enExample)
DE (1) DE60318567T2 (enExample)
DK (1) DK1501828T3 (enExample)
EA (1) EA009682B1 (enExample)
ES (1) ES2297165T3 (enExample)
IL (2) IL164796A0 (enExample)
MX (1) MXPA04010474A (enExample)
PT (1) PT1501828E (enExample)
RS (1) RS51407B (enExample)
SI (1) SI1501828T1 (enExample)
UA (1) UA78035C2 (enExample)
WO (1) WO2003091249A1 (enExample)
ZA (1) ZA200408023B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60318567T2 (de) 2002-04-25 2009-02-19 Laboratoires Serono S.A., Coinsins Piperazinbenzothiazole als wirkstoffe in der behandlung von ischämien und krankheiten des zns-systems
HRP20070527T3 (en) * 2003-09-12 2007-12-31 Laboratoires Serono Sa Benzothiazole derivatives for the treatment of diabetes
WO2005118543A1 (ja) * 2004-06-03 2005-12-15 Ono Pharmaceutical Co., Ltd. キナーゼ阻害薬およびその用途
JP5144271B2 (ja) * 2004-11-17 2013-02-13 アレス トレーディング ソシエテ アノニム ベンゾチアゾ−ル製剤、及びそれらの使用
US7838522B2 (en) 2004-11-17 2010-11-23 Ares Trading S.A. Benzothiazole formulations and use thereof
BRPI0613042A2 (pt) * 2005-07-15 2010-12-14 Serono Lab inibidores de jnk para o tratamento de endometriose
KR20080044836A (ko) 2005-07-15 2008-05-21 라보라뚜와르 세로노 에스. 에이. 자궁내막증 치료용 ｊｎｋ 억제제
WO2008125518A2 (en) * 2007-04-17 2008-10-23 Merck Serono S.A. Process for the preparation of piperazine benzothiazoles
KR101368079B1 (ko) * 2008-05-16 2014-03-14 에프. 호프만-라 로슈 아게 Ｊｎｋ 의 억제제
CA2799328C (en) * 2010-06-04 2018-02-20 Humberto Bartolome Arzeno 2 -amino- pyrimidine derivatives useful as inhibitors of jnk
US8471027B2 (en) * 2011-04-06 2013-06-25 Hoffmann-La Roche Inc. Adamantyl compounds
WO2014114186A1 (zh) * 2013-01-24 2014-07-31 山东亨利医药科技有限责任公司 Jnk抑制剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4153574B2 (ja) * 1997-09-10 2008-09-24 トーアエイヨー株式会社 新規なピペリジン誘導体、その製造法およびそれを含有する循環器官用剤
EP1110957A1 (en) * 1999-12-24 2001-06-27 Applied Research Systems ARS Holding N.V. Benzazole derivatives and their use as JNK modulators
EP1193256A1 (en) * 2000-09-27 2002-04-03 Applied Research Systems ARS Holding N.V. Pharmaceutically active benzsulfonamide derivatives as inhibitors of JNK proteins
DE60318567T2 (de) 2002-04-25 2009-02-19 Laboratoires Serono S.A., Coinsins Piperazinbenzothiazole als wirkstoffe in der behandlung von ischämien und krankheiten des zns-systems

Also Published As

Publication number Publication date
IL164796A (en) 2013-02-28
EP1501828B1 (en) 2008-01-09
US20050261304A1 (en) 2005-11-24
ZA200408023B (en) 2005-11-30
ES2297165T3 (es) 2008-05-01
DK1501828T3 (da) 2008-03-10
AU2003233067A1 (en) 2003-11-10
AU2003233067B2 (en) 2009-01-08
DE60318567D1 (de) 2008-02-21
CA2481763A1 (en) 2003-11-06
BRPI0309594A2 (pt) 2016-11-16
EA009682B1 (ru) 2008-02-28
RS92804A (sr) 2006-12-15
EP1501828A1 (en) 2005-02-02
CA2481763C (en) 2011-06-14
PT1501828E (pt) 2008-02-11
MXPA04010474A (es) 2004-12-13
KR100948469B1 (ko) 2010-03-17
EA200401423A1 (ru) 2005-04-28
WO2003091249A1 (en) 2003-11-06
KR20040104572A (ko) 2004-12-10
UA78035C2 (en) 2007-02-15
RS51407B (sr) 2011-02-28
CN1310911C (zh) 2007-04-18
BRPI0309594A8 (pt) 2017-04-11
ATE383356T1 (de) 2008-01-15
CY1107204T1 (el) 2012-11-21
JP2006504631A (ja) 2006-02-09
CN1662528A (zh) 2005-08-31
IL164796A0 (en) 2005-12-18
JP4523289B2 (ja) 2010-08-11
US7314878B2 (en) 2008-01-01
HK1075664A1 (en) 2005-12-23
DE60318567T2 (de) 2009-02-19

Similar Documents

Publication Publication Date Title
CY1107204T1 (el) Πιπεραζινοβενζοθειαζολια ως ουσιες για την θεραπευτικη αντιμετωπιση εγκεφαλικων ισχαιμικων διαταραχων ή διαταραχων του κνς
ATE524169T1 (de) Therapeutische strategien für die prävention und behandlung der alzeheimer-krankheit
MX2007012374A (es) Metodos y composiciones para el tratamiento de condiciones relacionadas con cns.
DE60332604D1 (de) Azolylaminoazine als proteinkinasehemmer
DE60314603D1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
MY135841A (en) Novel benzodioxoles
ATE466580T1 (de) Azolylaminoazine als proteinkinasehemmer
DK1242415T3 (da) 3-thiazol-4-yl-pyrolidinderivater som AMP-specifikke phosphodiesteraseinhibitorer
DE602004024572D1 (de) Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
MY135856A (en) Nicotinamide derivatives useful as pde4 inhibitors
PL377587A1 (pl) Pochodne hydroksyetyloaminy do leczenia choroby Alzheimera
PL1789398T3 (pl) Pochodne 2-amino-chinazoliny użyteczne jako inhibitory ß-sekretazy (BACE)
MXPA04007031A (es) Derivados benzofurano y benzotiofeno utiles en el tratamiento de desordenes hiper-proliferativos.
DE60233350D1 (de) IMIDAZOi2,1-B -1,3,4-THIADIAZOLE SULFONAMIDES
BR0209541A (pt) Uso das imidazotriazinonas 2-fenil-substituìdas
ECSP055844A (es) Nuevos compuestos triciclicos
WO2005117979A3 (en) Use of il-17 in the treatment of fertility-related disorders
MXPA05011699A (es) Inhibidores de la bomba de protones para el tratamiento de trastornos del abdomen inferior.
MX2007006754A (es) Derivados de indenilo y uso de los mismos para el tratamiento de trastornos neurologicos.
GB0407025D0 (en) Novel compounds
SG148840A1 (en) Indole derivatives useful for the treatment of cns disorders
MY136138A (en) Hexacyclic compounds
EA200200750A1 (ru) Новое терапевтическое применение еноксапарина
NO20050146L (no) N,N-disubstituerte diazocykloalkaner nyttige i behandling av CNS-forstyrrelser grunnet serotonergisk dysfunksjon
TNSN05154A1 (en) Use of levocetirizine for the treatment of persistent allergic rhinitis